Clinical Trial Update: Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence [Phase 3]

View source ↗

Summary

A Phase 3 extension study update for Probuphine assessing safety and efficacy in opioid dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Probuphine (buprenorphine implant)

Snippet

Sponsor: Titan Pharmaceuticals | Conditions: Opioid Dependence | Phase 3 | Status: COMPLETED